In the early stages of Parkinson's, which medication is used alone or with carbidopa-levodopa to help with symptom fluctuations?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

In the early stages of Parkinson's, which medication is used alone or with carbidopa-levodopa to help with symptom fluctuations?

Explanation:
Managing fluctuations in early Parkinson’s relies on preserving dopamine signaling. Selegiline is a selective MAO-B inhibitor, which slows the breakdown of dopamine in the brain. By increasing and prolonging dopamine availability, it helps smooth out motor fluctuations and wearing-off. It can be used on its own in early disease or added to carbidopa-levodopa to extend on-time and reduce OFF periods. Levodopa and its combination with carbidopa are powerful symptom relievers, but they don’t specifically address fluctuations the same way MAO-B inhibition does. Rasagiline is another MAO-B inhibitor with a similar effect, but selegiline is the classic option described for this use.

Managing fluctuations in early Parkinson’s relies on preserving dopamine signaling. Selegiline is a selective MAO-B inhibitor, which slows the breakdown of dopamine in the brain. By increasing and prolonging dopamine availability, it helps smooth out motor fluctuations and wearing-off. It can be used on its own in early disease or added to carbidopa-levodopa to extend on-time and reduce OFF periods. Levodopa and its combination with carbidopa are powerful symptom relievers, but they don’t specifically address fluctuations the same way MAO-B inhibition does. Rasagiline is another MAO-B inhibitor with a similar effect, but selegiline is the classic option described for this use.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy